本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Assembly Biosciences Inc.

25.48
-0.6300-2.41%
盤後25.480.00000.00%19:30 EDT
成交量:34.88萬
成交額:897.83萬
市值:5.19億
市盈率:-9,925.98
高:26.69
開:26.11
低:25.13
收:26.11
52周最高:39.71
52周最低:20.23
股本:2,036.06萬
流通股本:917.37萬
量比:0.79
換手率:3.80%
股息:- -
股息率:- -
每股收益(TTM):-0.0026
每股收益(LYR):-0.5461
淨資產收益率:-0.03%
總資產收益率:-2.67%
市淨率:1.70
市盈率(LYR):-46.66

資料載入中...

2021/02/25

重要事件披露

8-K - Current report
2021/02/17

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/27

重要事件披露

8-K - Current report
2021/01/12

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/08

重要事件披露

8-K - Current report
2020/11/17

重要事件披露

8-K - Current report
2020/11/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

重要事件披露

8-K - Current report
2020/10/21

重要事件披露

8-K - Current report
2020/09/03

SEC問詢函

CORRESP [Cover] - Correspondence